Towards an oral influenza vaccine: comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-12-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2007.10.045PMID 18061315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Needle-free vaccine delivery

  2007cited by this paper
• A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products.

  2007cited by this paper
• Time-controlled oral delivery systems for colon targeting

  2006cited by this paper
• Needle-free vaccine delivery.

  2006cited by this paper
• Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers

  2006cited by this paper
• Immunization without needles

  2005cited by this paper
• Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults.

  2005cited by this paper
• Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization.

  2005cited by this paper
• The virosome concept for influenza vaccines.

  2005influential reference
• Oral pulsatile drug delivery systems

  2005cited by this paper
• Poliomyelitis: very small risks and very large risks

  2004cited by this paper
• Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin.

  2004cited by this paper
• Antigen delivery systems

  2004cited by this paper
• Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines

  2004cited by this paper
• New generation of mucosal adjuvants for the induction of protective immunity

  2003cited by this paper
• Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges.

  2003cited by this paper
• Low investment in immunization and vaccines threatens global health.

  2003cited by this paper
• Interleukin‐18 plays a role in both the alum‐induced T helper 2 response and the T helper 1 response induced by alum‐adsorbed interleukin‐12

  2003cited by this paper
• Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine.

  2002influential reference
• Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

  2002cited by this paper
• Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.

  2002cited by this paper
• The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology

  2001cited by this paper
• Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

  2001cited by this paper
• Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity.

  2001cited by this paper
• Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).

  2001cited by this paper
• Oral Administration of Influenza Vaccine in Combination with the Adjuvants LT-K63 and LT-R72 Induces Potent Immune Responses Comparable to or Stronger than Traditional Intramuscular Immunization

  2001influential reference
• Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.

  2000cited by this paper
• Mucosal immunity to influenza without IgA: an IgA knockout mouse model.

  1999cited by this paper
• The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).

  1999cited by this paper
• Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice.

  1999cited by this paper
• Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

  1998cited by this paper
• Towards an oral influenza vaccine.

  1997cited by this paper
• Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

  1997cited by this paper
• Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine.

  1997cited by this paper
• Interleukin-4 causes delayed virus clearance in influenza virus-infected mice

  1996cited by this paper
• Antigen sampling across epithelial barriers and induction of mucosal immune responses.

  1996cited by this paper
• Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.

  1996cited by this paper
• Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin

  1996cited by this paper
• Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.

  1996cited by this paper
• Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

  1995cited by this paper
• Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens.

  1995cited by this paper
• Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.

  1995cited by this paper
• Enteric immunization of mice against influenza with recombinant vaccinia.

  1994cited by this paper
• Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose.

  1994cited by this paper
• Oral immunization with influenza virus in biodegradable microspheres.

  1993cited by this paper
• Mucosal immunity: implications for vaccine development.

  1992cited by this paper
• A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization

  1992cited by this paper
• Cytoplasmic high-level expression of a soluble, enzymatically active form of the Escherichia coli penicillin-binding protein 5 and purification by dye chromatography.

  1992cited by this paper
• Passive transfer of local immunity to influenza virus infection by IgA antibody.

  1991cited by this paper
• Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro

  1991cited by this paper
• Immunoglobulin A mediation of murine nasal anti-influenza virus immunity

  1991cited by this paper
• Overview of the mucosal immune system.

  1989cited by this paper
• Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding

  1988cited by this paper
• Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

  1988influential reference
• Bacteriophage lambda cloning system for the construction of directional cDNA libraries.

  1987influential reference
• Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin.

  1987cited by this paper
• Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine

  1987cited by this paper
• Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine.

  1986cited by this paper
• Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

  1986cited by this paper
• Perinuclear dense bodies: characterization as DNA-containing structures using enzyme-linked gold granules.

  1986cited by this paper
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

  1984cited by this paper
• Immunization against influenza in humans using an oral enteric-coated killed virus vaccine.

  1984cited by this paper
• Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

  1979cited by this paper
• Assay of proteins in the presence of interfering materials.

  1976cited by this paper
• Influenza infection in ferrets: role of serum antibody in protection and recovery

  1976cited by this paper
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

  1972cited by this paper

• Mucosal and systemic immune responses following mucosal immunisation of tetanus toxoid entrapped in lipid nanoparticles prepared by microwave reactor.

  2022cites this paper
• Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection

  2020cites this paper
• Sales and immunogenicity of commercial vaccines to H9N2 low pathogenic avian influenza virus in Korea from 2007 to 2017.

  2020cites this paper
• Wilkhu, Jitinder S. and McNeil, Sarah E. and Anderson, David E. and Perrie, Yvonne (2013) Characterization and optimization of bilosomes

  2018cites this paper
• Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza

  2017cites this paper
• Intranasal and sublingual delivery of inactivated polio vaccine.

  2017cites this paper
• An Overview of History, Evolution, and Manufacturing of Various Generations of Vaccines

  2017cites this paper
• Non-invasive administration of biodegradable nano-carrier vaccines.

  2017cites this paper
• Evaluation of LACK Gene Diversity in Leishmania major Using PCR and Sequencing Methods

  2017cites this paper
• Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.

  2016cites this paper
• Susceptibility to Invasive Meningococcal Disease: Polymorphism of Complement System Genes and Neisseria meningitidis Factor H Binding Protein

  2015cites this paper
• Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.

  2014cites this paper
• Increased Immunoaccessibility of MOMP Epitopes in a Vaccine Formulated with Amphipols May Account for the Very Robust Protection Elicited against a Vaginal Challenge with Chlamydia muridarum

  2014cites this paper
• Chlamydia muridarum Challenge with Protection Elicited against a Vaginal Amphipols May Account for the Very Robust Epitopes in a Vaccine Formulated with Increased Immunoaccessibility of MOMP

  2014cites this paper
• Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer

  2013cites this paper
• Health-economic modelling of human Papillomavirus vaccination

  2013cites this paper
• Characterization and optimization of bilosomes for oral vaccine delivery

  2013cites this paper
• Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses.

  2012cites this paper
• Oral vaccination with inactivated influenza vaccine induces cross-protective immunity.

  2012cites this paper
• Immunogenicity and protection of oral influenza vaccines formulated into microparticles.

  2012cites this paper
• Towards tailored vaccine delivery: needs, challenges and perspectives.

  2012cites this paper
• Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer

  2012cites this paper
• Microneedle and mucosal delivery of influenza vaccines

  2012cites this paper
• Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE).

  2011cites this paper
• Vaccination with hemagglutinin produced in Trichoplusia ni larvae protects chickens against lethal H5N1 challenge

  2011cites this paper
• Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine.

  2011cites this paper
• The Evolution and Value of Diphtheria Vaccine

  2011cites this paper
• Synthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvant.

  2011cites this paper
• Binding to complement factors and activation of the alternative pathway by Acanthamoeba.

  2011cites this paper
• Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile.

  2011cites this paper
• Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particles.

  2010cites this paper
• Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice.

  2010cites this paper
• Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant

  2010cites this paper
• Tick-borne encephalitis: from childhood to golden age does increased mobility mean increased risk? Conference report of the 11th meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE).

  2010cites this paper
• Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

  2010cites this paper
• Needle-free influenza vaccination.

  2010cites this paper
• Colonic treatments and targets: issues and opportunities

  2009cites this paper
• Strategies in Oral Immunization

  2009cites this paper
• Polymer microneedles for transdermal delivery of biopharmaceuticals

  2009cites this paper
• Complement and immune defense: from innate immunity to human diseases.

  2009cites this paper
• GENERATION AND CHARACTERIZATION OF THE CELLULAR IMMUNE RESPONSE TO A CLOSTRIDIUM PERFRINGENS ANTI-SIV MUCOSAL VACCINE

  2008cites this paper